SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

April 16, 2012 08:35 ET

MMRGlobal Continues MMRPro Install Program With Regent Surgical Health-Managed Ambulatory Surgery Centers

LOS ANGELES, CA--(Marketwire - Apr 16, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that it will continue installing MMRPro systems at ambulatory surgery centers ("ASCs") managed by Regent Surgical Health ("Regent"), a leading surgery center management and development company. Last September, MMR installed an MMRPro system at the Peninsula Ambulatory Surgical Center in Bayonne, New Jersey, managed by Regent, demonstrating the effectiveness of the MMRPro electronic document management and imaging system. Based on the success of the Peninsula installation, MMR will install additional MMRPro systems at the Regent-managed ASC in Fort Myers, Florida, as well as two other Regent-managed surgical centers that are slated to open in New Jersey and Illinois later this quarter. Regent currently manages 21 ambulatory surgery centers across the United States.

According to Joyce Thomas, Senior Vice President of Operations for Regent Surgical Health, "MMRPro has proven itself to be a good solution for our document management and imaging needs. Not only is it reliable and secure, but it is also very easy to use. In fact, we will be installing more MMRPro systems in our other facilities." Regent, based in Westchester, Illinois, is known for its expertise in joint venture and ownership model as a buyer, developer and manager of ASCs.

MMR is a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals. With more than 22 million surgeries being performed a year in more than 5,000 ambulatory surgery centers in the U.S., MMR considers the ambulatory surgical center market important to the Company's continued growth. MMRPro systems have successfully scanned over one million patient records over the last 12 months.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit View demos and video tutorials of the Company's products and services at

About Regent Surgical Health

Regent Surgical Health is among the nation's leading surgery center management and development companies, and the most experienced company offering physician/hospital joint venture partnerships. Regent has an unmatched record for delivering sustainable profitability while enabling physician partners to maintain clinical autonomy and financial control. The company invests capital side by side with hospital and physician partners and firmly believes the by-product of excellent care and efficiency is financial success. To learn more about Regent Surgical Health and other physician/hospital alliance opportunities, visit our web site at

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "intend," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue." These forward-looking statements are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community; business prospects, results of operations or financial condition; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; maintaining, developing and defending our intellectual property rights; marketing and exploitation of our patent portfolio both in the U.S. and internationally; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact Information